Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed the day trading at $27.75 up 0.47% from the previous closing price of $27.62. In other words, the price has increased by $0.47 from its previous closing price. On the day, 3.88 million shares were traded. APLS stock price reached its highest trading level at $28.87 during the session, while it also had its lowest trading level at $27.63.
Ratios:
For a better understanding of APLS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 794.68. For the most recent quarter (mrq), Quick Ratio is recorded 3.16 and its Current Ratio is at 3.77. In the meantime, Its Debt-to-Equity ratio is 3.01 whereas as Long-Term Debt/Eq ratio is at 2.96.
On May 09, 2025, BofA Securities Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $23.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $44.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $44 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 17 ’25 when Francois Cedric sold 19,725 shares for $20.21 per share. The transaction valued at 398,735 led to the insider holds 331,605 shares of the business.
Watson David O. sold 5,000 shares of APLS for $97,750 on Jul 16 ’25. The General Counsel now owns 128,730 shares after completing the transaction at $19.55 per share. On Jul 17 ’25, another insider, Francois Cedric, who serves as the Officer of the company, bought 19,725 shares for $20.15 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 3504547584 and an Enterprise Value of 3599529984. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.64 while its Price-to-Book (P/B) ratio in mrq is 22.40. Its current Enterprise Value per Revenue stands at 4.77 whereas that against EBITDA is -19.12.
Stock Price History:
The Beta on a monthly basis for APLS is 0.72, which has changed by -0.2805289 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $41.94, while it has fallen to a 52-week low of $16.10. The 50-Day Moving Average of the stock is 37.20%, while the 200-Day Moving Average is calculated to be 13.15%.
Shares Statistics:
Over the past 3-months, APLS traded about 2.48M shares per day on average, while over the past 10 days, APLS traded about 2832770 shares per day. A total of 126.19M shares are outstanding, with a floating share count of 103.85M. Insiders hold about 17.73% of the company’s shares, while institutions hold 101.12% stake in the company. Shares short for APLS as of 1753920000 were 22092024 with a Short Ratio of 8.92, compared to 1751241600 on 26148815. Therefore, it implies a Short% of Shares Outstanding of 22092024 and a Short% of Float of 23.040001.
